This inventor holds 3 USPTO granted patents and 13 published patent applications and 5 EPO patents. Top assignees: Bruker Daltonik Gmbh, Leibniz-Institut Fur Analytische Wissenschaften - Isas - E.v., Other. Active years: 2003-2019.
Company Filing History:

Years Active: 2003-2019
Title: Helmut E Meyer: Innovator in Biomarker Research
Introduction
Helmut E Meyer is a distinguished inventor based in Recklinghausen, Germany. He has made significant contributions to the field of biomarker research, particularly in the diagnosis and treatment of liver diseases and cholangiocellular carcinoma. With a total of 3 patents to his name, his work has the potential to impact medical diagnostics and therapeutic strategies.
Latest Patents
Meyer’s latest patents include innovative methods for identifying biomarkers for cholangiocellular carcinoma (CCC). This invention relates to a method for identifying specific marker proteins that can be used for diagnosis, surveillance, and treatment of CCC. Additionally, he has developed a diagnostic device that utilizes these biomarkers to identify novel pharmaceutical compounds for treating CCC. Another significant patent focuses on the diagnostic investigation of biological samples for liver inflammation, specifically hepatic fibrosis and cirrhosis. This method involves analyzing protein concentrations to indicate the presence of liver inflammation, providing a crucial tool for early diagnosis and intervention.
Career Highlights
Throughout his career, Helmut E Meyer has worked with notable organizations such as Bruker Daltonik GmbH and the Leibniz Institute for Analytical Sciences (ISAS). His experience in these institutions has allowed him to refine his expertise in analytical sciences and biomarker research.
Collaborations
Meyer has collaborated with several professionals in his field, including Barbara Sitek and Juliet Padden. These collaborations have contributed to the advancement of his research and the development of his patented technologies.
Conclusion
Helmut E Meyer stands out as a prominent inventor in the realm of biomarker research, with a focus on liver diseases and cholangiocellular carcinoma. His innovative patents and collaborations reflect his commitment to advancing medical diagnostics and treatment options.